LabEx
Français

TRAIL Conference (LabEx TRAIL)

Envoyée le Tuesday 08 September 2015
par LabEx TRAIL
TRAIL Laboratory of excellence, Translational Research and Advanced Imaging Laboratory

Tuesday 08 September 2015

Save the date

 - - - - - - - -

TRAIL CONFERENCE: "Respective value of PET and MRI in the presurgical evaluation of patients with partial epilepsy", 7th of October, 2015, 16:00-17:30, Pellegrin University Hospital , Conference room Broussin-Delorme

"Respective value of PET and MRI in the presurgical evaluation of patients with partial epilepsy", Pr Franck Semah, Head of the Department of Radiology, Nuclear Medicine and Physiology, University Hospital of Lille, France

Wednesday the 7th of October, 2015, 16:00-17:30, Pellegrin University Hospital, Broussin-Delorme conference room

Contact: Michèle Allard, michele.allard@u-bordeaux.fr, INCIA, UMR5287 CNRS University of Bordeaux, Team Neuroimagery and human cognition

Dr. Franck Semah received his M.D. degree from Paris VI University in 1990. After a neurology residency in Paris, he worked at la Salpêtrière Hospital during 4 years as neurologist. He then completed his specialist nuclear medicine training and moved to the Nuclear Medicine department of the Commissariat à l’Energie Atomique (CEA) in Orsay, where he became in 1999 head of the Nuclear Medicine and Clinical Research Unit.
In 2008, he joined the University Hospital of Lille, where he became professor of Nuclear Medicine. He is now Head of the Department of Radiology, Nuclear Medicine and Physiology in Lille.

His research is focused on brain imaging in epilepsy and neurodegenerative disorders, such as Alzheimer disease. One of his main interests is the anatomical and functional alterations of the hippocampus in temporal lobe epilepsy. He has published more than 100 articles in clinical and imaging journals.


 - - - - - - - -

TRAIL - Logos partenaires


 - - - - - - - -

Mentions légales - Labex Trail
Directeur de publication : Vincent Dousset / Responsable éditorial : Jean-François BAUGER
Pour vous désabonner / to unsubscribe: suivre ce lien / click here